HAVELET FINANCE LIMITED

  Intravenous fluid is intended to be given to a patient intravenously, directly through the circulatory system. Intravenous fluids are extensively used to treat electrolyte imbalances, maintain fluid balance, and replace fluid losses.   Fluids are injected   when one’s body fluid volume falls. Blood loss, fall in electrolyte level due to fluid volume falls causes bodily dysfunction.   Havelet Finance Limited provide financing for intravenous fluid plant worldwide from the beginning of the projects to the end. Factors that Drives Market for Financing Intravenous Fluid Plant The factors which drive financing the  market for intravenous  (IV) are cost-effectiveness, increasing the prevalence of chronic diseases, the rise of cholera, and growing acceptance of vitamin C intravenous for colorectal cancer, rise in geriatric population, and increase in several dialysis patients, expanding  healthcare expenditure  and increasing government endorsement. With the increasing gastrointestinal diso

  How Project Finance Could Revolutionize Global healthcare. A Case Study of Africa. IFC  in it’s adventure in Africa described healthcare system as most deteriorating and  overwhelmingly the worst in the world! The way forward to eradicate such daunting situation is to engage in international project finance for succor within healthcare system. The countries with the highest rates of maternal death,  death under 5 years old,  deaths from trauma & injury and deaths from infectious disease are nearly all in Africa. Why is Healthcare in Africa Poor? Ultimately, it comes down to resources. Especially as the price of healthcare globally continues to increase. Jon Guber, a Professor of Economics at MIT describes how in 1950, the American government spent 5% of GDP on healthcare. In 2012, it spent almost 20% of GDP on healthcare. By 2075, its projected to be 40%. That means 40 cents out of every $1 generated in America will go to healthcare!  Africa makes up 16% of the world population a